Adverse events with HeartMate-3 Left ventricular assist device: Results from the Manufacturer and User Facility Device Experience (MAUDE) database

Código QR

Adverse events with HeartMate-3 Left ventricular assist device: Results from the Manufacturer and User Facility Device Experience (MAUDE) database

None.

Guardado en:

Detalles Bibliográficos
Autores principales:	Joseph N. Heaton, Sohrab Singh, Matthew Li, Saraschandra Vallabhajosyula
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Left ventricular assist device Post-marketing surveillance HeartMate-3 Heart failure Complications Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/00ad4be4df1c497d9651ceedbf242c0c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

ECMELLA: Uso combinado de dispositivos de asistencia ventricular izquierda en el manejo del shock cardiogénico postinfarto agudo al miocardio
por: Hameau D.,René, et al.
Publicado: (2020)

Quercetin Inhibits Left Ventricular Dysfunction Induced by Chronic Stress in Rats
por: Bin-Jaliah,Ismaeel
Publicado: (2017)

Results of surgical treatment of postinfarction left ventricular aneurysm complicated with ventricular tachycardia with use of 3D-navigation system CARTO™
por: V. N. Iljinov, et al.
Publicado: (2014)

Unrecognized concomitant ventricular septal rupture and left ventricular aneurysm 10 months after myocardial infarction in a patient presenting with chronic heart failure
por: Masashi Kawamura, et al.
Publicado: (2021)

Impaired Cardiac Sympathetic Innervation Increases the Risk of Cardiac Events in Heart Failure Patients with Left Ventricular Hypertrophy and Mechanical Dyssynchrony
por: Takahiro Doi, et al.
Publicado: (2021)

Myocardial Recovery and the Failing Heart: Medical, Device and Mechanical Methods
por: Judith Z. Goldfinger, et al.
Publicado: (2014)

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE
por: Safia Batool, et al.
Publicado: (2020)

Overlap phenotypes of the left ventricular noncompaction and hypertrophic cardiomyopathy with complex arrhythmias and heart failure induced by the novel truncated DSC2 mutation
por: Yubi Lin, et al.
Publicado: (2021)

Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices
por: Bożena Szyguła-Jurkiewicz, et al.
Publicado: (2021)

Left ventricular assistant devices for end-stage heart failure: report of two cases
por: Pedemonte,Oneglio, et al.
Publicado: (2014)

Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania
por: Mavrea AM, et al.
Publicado: (2015)

Successful device closure of a post-infarction ventricular septal defect
por: Choi SW, et al.
Publicado: (2016)

A comparative study on echocardiographic evaluation of left ventricular mass and function in normotensive diabetic and non-diabetic patient
por: Tanmay Mukhopadhyay, et al.
Publicado: (2021)

A Universal New Definition of Heart Failure With Improved Ejection Fraction for Patients With Coronary Artery Disease
por: Haozhang Huang, et al.
Publicado: (2021)

Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials
por: Johannes Grand, et al.
Publicado: (2021)

The Effects of Hypertension Stages on N-Terminal-Pro Brain Natriuretic Peptide (NT-Pro-BNP) Level and Left Ventricular Ejection Fraction
por: Kati Sriwiyati, et al.
Publicado: (2019)

Asistencia ventricular derecha con bomba centrífuga
por: Pedemonte V,Oneglio, et al.
Publicado: (2008)

Operación de Fontan: resultados inmediatos y a mediano plazo con anastomosis cavopulmonar total
por: Becker R,Pedro, et al.
Publicado: (2002)

Estado actual de los sistemas de soporte circulatorio mecánico: State of the art
por: Mc-Nab M,Paul, et al.
Publicado: (2006)

The role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2011)

Non-Surgical Resolution of Inflow Cannula Obstruction of a Left Ventricular Assist Device: A Case Report
por: Yoonseo Lee, et al.
Publicado: (2021)

The Impact of Deep Y Descent on Hemodynamics in Patients With Heart Failure and Preserved Left Ventricular Systolic Function
por: Daisuke Harada, et al.
Publicado: (2021)

Long-Term renal function after implantation of continuous-flow left ventricular assist devices: A single center study
por: Chie Bujo, et al.
Publicado: (2021)

Cardiac resynchronization therapy pacemaker: critical appraisal of the adaptive CRT-P device
por: Daoud GE, et al.
Publicado: (2016)

Diagnostic and Prognostic Value of a TDI-Derived Systolic Wall Motion Analysis as a Screening Modality for Allograft Rejection after Heart Transplantation
por: Isabell A. Just, et al.
Publicado: (2021)

Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients
por: Huang YS, et al.
Publicado: (2014)

Patterns of left ventricular remodeling among patients with essential and secondary hypertension
por: Radulescu,Dan, et al.
Publicado: (2013)

Prognostic Role of Subclinical Congestion in Heart Failure Outpatients: Focus on Right Ventricular Dysfunction
por: Andrea Lorenzo Vecchi, et al.
Publicado: (2021)

Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II
por: Bunster,Nicolás, et al.
Publicado: (2014)

FREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%
por: Ammara Avais, et al.
Publicado: (2020)

Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure
por: Li-fang Ye, et al.
Publicado: (2021)

Cardiotrofina-1 circulante puede diferenciar la hipertrofia ventricular fisiológica del atleta de la hipertrofia patológica del paciente hipertenso
por: Gabrielli,Luigi, et al.
Publicado: (2009)

A Complicated Course of Brain Tumor Resection in a Patient with a Left Ventricular Assist Device
por: Nimesh Patel, et al.
Publicado: (2021)

Miocardiopatía no compactada: una serie de 15 casos
por: Enríquez R,Andrés, et al.
Publicado: (2011)

Hipertrofia ventricular izquierda con patrón de strain característico
por: Vega,Julián, et al.
Publicado: (2017)

Left ventricular systolic dysfunction among nocturnal myocardial infarctions
por: A Ghaemian, et al.
Publicado: (2004)

Tricuspid insufficiency after cardiac-implantable electronic device placement
por: Nismat Javed, et al.
Publicado: (2021)

FREQUENCY AND RISK FACTORS OF LEFT VENTRICULAR GEOMETRIC ABNORMALITIES IN HYPERTENSIVE PATIENTS: A STUDY BASED ON THE UPDATED CLASSIFICATION SYSTEM OF LEFT VENTRICULAR GEOMETRY
por: Fauzia Nazir, et al.
Publicado: (2020)

Heart Model A.I. Three-Dimensional Echocardiographic Evaluation of Left Ventricular Function and Parameter Setting
por: Xing YY, et al.
Publicado: (2021)

Valor pronóstico de la hiperuricemia en la insuficiencia cardíaca crónica
por: Martínez S,Alejandro, et al.
Publicado: (2004)